SCHEMBL1562801

SCHEMBL1562801

CNC(=O)/C=C\c1ccccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.65
▸ LMNA P02545 1/20 0.65
▸ NFKB1 P19838 2/20 0.63
▸ JUN P05412 1/20 0.63
▸ NFE2L2 Q16236 1/20 0.63
▸ CA1 P00915 1/20 0.61
▸ CA2 P00918 1/20 0.61
▸ CA4 P22748 1/20 0.61
▸ BCHE P06276 1/20 0.56
▸ GUSB P08236 1/20 0.56
▸ PELI1 Q96FA3 3/20 0.55
▸ CHRNA7 P36544 3/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ ALPL P05186 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9444501 1.00 MAPT (0.65) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL17305570 1.00 MAPT (0.65) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL14244199 0.83 HDAC8 (0.66) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL12426301 0.83 HDAC8 (0.66) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL17151526 0.81 MMP1 (0.46) MAPTLMNAPELI1KDM4ENPC1
SCHEMBL12425714 0.81 NFKB1 (0.63) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL29412622 0.81 NFKB1 (0.63) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL4254014 0.81 NFKB1 (0.63) MAPTLMNANFKB1JUNNFE2L2
Leucine SCHEMBL10491460 0.81 NFKB1 (0.46) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL18310156 0.81 EGFR (0.63) MAPTLMNANFKB1JUNNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0856065-B1 ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE UNIV NEBRASKA (US) 2003-06-25 — — EP claimed
US-6130049-A MEASURING ACTIVITY OF CATALYTIC ANTIBODIES BY CONTACTING PEPTIDE HAVING AT LEAST ONE ARGININE, LYSINE, OR PROLINE WITH TEST AND CONTROL SAMPLES AND PROMOTING CATALYTIC CLEAVAGE OF PEPTIDE; REDUCED ACTIVITY INDICATES DISEASE OR PREDISPOSITION THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2000-10-10 — — US claimed
EP-0856065-A4 ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE UNIV NEBRASKA (US) 2000-05-31 — — EP claimed
EP-0856065-A1 ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) 1998-08-05 — — EP claimed
WO-1997004125-A1 ASSAY METHODS AND KITS FOR DIAGNOSING AUTOIMMUNE DISEASE UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) 1997-02-06 — — WO claimed
JP-10099075-A — — None — — JP disclosed
US-20250290928-A1 METHOD, KIT AND DEVICE FOR DETECTING EXTRACELLULAR VESICLES CANON KABUSHIKI KAISHA (JP) 2025-09-18 — — US disclosed
EP-4617371-A1 METHOD, KIT AND DEVICE FOR DETECTING EXTRACELLULAR VESICLES CANON KABUSHIKI KAISHA (JP) 2025-09-17 — — EP disclosed
WO-2025089217-A1 COMPOUND FOR USE AS SUBSTRATE FOR EVALUATING ACTIVITY OF γ-D-GLUTAMYL-L-LYSYL ENDOPEPTIDASE 株式会社ヤクルト本社 2025-05-01 — — WO disclosed
WO-2024262350-A1 PEPTIDE OR SALT THEREOF, COMPOSITION CONTAINING SAME, AND COMPOSITION FOR SUPPRESSING DECLINE OF OR IMPROVING COGNITIVE FUNCTIONS サントリーホールディングス株式会社 2024-12-26 — — WO disclosed
WO-2024237199-A1 PROPHYLACTIC/THERAPEUTIC AGENT FOR PREGNANCY-INDUCED HYPERTENSION 国立大学法人金沢大学 2024-11-21 — — WO disclosed
WO-2024122520-A1 METHOD, KIT AND DEVICE FOR DETECTING EXTRACELLULAR VESICLES キヤノン株式会社 2024-06-13 — — WO disclosed
EP-0759768-A1 VASOACTIVE INTESTINAL POLYPEPTIDE Proteinix Company (US) 1997-03-05 — — EP disclosed
EP-0570554-A4 MONOCLONAL ANTIBODY AND ANTIBODY COMPONENTS ELICITED TO A POLYPEPTIDE ANTIGEN GROUND STATE IGEN INC (US) 1997-02-26 — — EP disclosed
US-5599538-A CATALYZING THE HYDROLYSIS OF THE PEPTIDE BONDE BETWEEN AMINO ACID RESIDUES, E.G. THE VASOACTIVE INTESTINAL PEPTIDE; ANTICARCINOGENIC AGENTS; VIRICIDES; BACTERICIDES; PROTOZOA; MEDICAL DIAGNOSIS IGEN, INC. (US) 1997-02-04 — — US disclosed
EP-0699763-A1 Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme TEIJIN LIMITED (JP) 1996-03-06 — — EP disclosed
WO-1995027496-A1 VASOACTIVE INTESTINAL POLYPEPTIDE PROTEINIX COMPANY (US) 1995-10-19 — — WO disclosed
US-5318897-A Catalytically cleaving a polypeptides IGEN, INC. (US) 1994-06-07 — — US disclosed
EP-0570554-A1 MONOCLONAL ANTIBODY AND ANTIBODY COMPONENTS ELICITED TO A POLYPEPTIDE ANTIGEN GROUND STATE IGEN, INC. (US) 1993-11-24 — — EP disclosed
WO-1993009247-A1 MONOCLONAL ANTIBODY AND ANTIBODY COMPONENTS ELICITED TO A POLYPEPTIDE ANTIGEN GROUND STATE IGEN, INC. (US) 1993-05-13 — — WO disclosed
Send feedback